baber/WOPTO huggingface dataset:
Patent AU-723783-B2 (AU)
Title: Pressure-responsive lockout valve and method of use
Inventor: WILLARD STEVEN N
IPC: A61F2/26
Filed: 1997-07-28
Granted: 2000-09-07
Abstract: The present invention provides a penile prosthesis comprising a fluid reservoir (16), an inflatable member (22) and a lockout valve (10) for controlling the flow of a fluid between the fluid reservoir and the inflatable member and preventing inadvertent auto-inflation of the inflatable member (22), the lockout valve (10) comprising a valve body (26) having an inlet port (28) in fluid communication with the reservoir (16) and an outlet port (30) in fluid communication with the inflatable member (22), a valve seat (32) formed in the valve body (26), the valve seat (32) defining a flow aperture (34) for flow of the fluid between the inlet port (28) and the outlet port (30), and a valve member (38) that is movable between a closed position in sealing contact with the valve seat (32) in which the valve member (38) prevents flow of the fluid through the flow aperture (34) and an open position in which the valve member (38) allows flow of fluid through the flow aperture (34), wherein the valve member (38) is movable to the open position in response to at least a threshold level of negative pressure applied at the outlet port (30), thereby allowing fluid to flow through the flow aperture (34).
Patent AU-711066-B2 (AU)
Title: Receptor for a Bacillus thuringiensis toxin
Inventor: BULLA LEE A
IPC: C12N15/00
Filed: 1995-10-10
Granted: 1999-10-07
Abstract: The cDNA that encodes a glycoprotein receptor from the tobacco hornworm which binds a Bacillus thuringiensis toxin has been obtained and sequenced. The availability of this cDNA permits the retrieval of DNAs encoding homologous receptors in other insects and organisms as well as the design of assays for the cytotoxicity and binding affinity of potential pesticides and the development of methods to manipulate natural and/or introduced homologous receptors and, thus, to destroy target cells, tissues and/or organisms.
Patent AU-620129-B2 (AU)
Title: Process and device for the purification of raw gas from solids gasification reactors
Inventor: HEDERER HARTMUT DR
IPC: C10J3/84
Filed: 1989-08-16
Granted: 1992-02-13
Abstract: In a process and apparatus for purifying raw gas from solids gasification, containing granular and dusty solids particles, a solution is to be found, by means of which solids particles of any size are largely removed from the raw gas before entry to downstream cooling devices. This is achieved when the raw gas is passed in a first purification stage from the gasification zone in a straight line in the direction of a gas-holding space, whereby the granular solids particles are precipitated at the bottom of the gas-holding space and then, in a second purification stage, the partially purified raw gas is laterally deflected from the gas-holding space and undergoes a change to a velocity reduced by a factor of at least 3 and, after a further gas deflection, is passed substantially in the vertical direction through a solids filter, where the dusty solids particles are removed from the raw gas. <IMAGE>
Patent AU-753592-B2 (AU)
Title: Method and device for detecting a signal having a certain frequency
Inventor: HURME HARRI
IPC: H04Q1/446
Filed: 1999-05-11
Granted: 2002-10-24
Abstract: An electric device is intended for detecting the presence of a signal having a certain frequency (401) in a line connection (301). It comprises at least three energy-storing components (302, 303, 304, 305, 501, 502, 503, 504) connected in parallel to the line connection, switching means (306) for making a connection selectively from each energy-storing components to a certain reference, means (CLK1, CLK2) for controlling the switching means at a predetermined frequency, and means (307, 308, 309) for measuring a certain quantity comparable to the energy stored from each energy-storing component.
Patent AU-752196-B2 (AU)
Title: Method for purification of Borrelia lipoprotein OSPA
Inventor: DESMONS PIERRE
IPC: A61K38/00
Filed: 1999-05-25
Granted: 2002-09-12
Abstract: The present invention provides a method for purification of Borrelia lipoprotein OspA suitable for human clinical use whereby a host cell expressing lipoprotein OspA is lysed in the presence of a zwitterionic detergent followed by several chromatographic steps in a nonionic detergent.
Patent AU-698130-B2 (AU)
Title: Electromagnetic resonant filter
Inventor: LITHGOW ROBERT D
IPC: H01P7/06
Filed: 1995-11-30
Granted: 1998-10-22
Abstract: A filter for processing electromagnetic signals has a housing with resonators located inside the cavity of that housing. The resonators, which may be made in part from superconducting material, have rounded exterior surfaces without corners to provide a more desirable coating surface and uniform electric field around the resonators. The filter housing may be composed of a plurality of housing cells, each containing a resonator. These cells can be removably attached to other cells so that resonators may be added to or removed from the filter as may be required for a particular application.
Patent AU-718753-B2 (AU)
Title: Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
Inventor: DESAI NEIL P
IPC: A61K47/42
Filed: 1997-09-24
Granted: 2000-04-20
Abstract: In accordance with the present invention, there are provided compositions and methods useful for the  in vivo  delivery of substantially water-insoluble pharmacologically active agents (such as the anticancer drug paclitaxel) in which the pharmacologically active agent is delivered in the form of suspended particles coated with protein (which acts as a stabilizing agent).  In particular, protein and pharmacologically active agent in a biocompatible dispersing medium are subjected to high shear, in the absence of any conventional surfactants, and also in the absence of any polymeric core material for the particles. The use of specific composition and preparation conditions enables the reproducible production of unusually small nanoparticles of less than 200 nm diameter, which can be sterile-filtered.
Patent AU-525423-B2 (AU)
Title: Substitutted amino acids
Inventor: KRASTINAT WALTER DR
IPC: C07C233/47
Filed: 1979-06-12
Granted: 1982-11-04
Abstract: Acylbiphenylylaminoalkanoic acids of the general formula I   <IMAGE> in which R<1> signifies an aliphatic or alicyclic hydrocarbon radical or an optionally substituted phenyl group, A signifies an optionally substituted and/or hydrogenated biphenylyl radical and n signifies a positive whole number from 3 to 5, as well as their salts of inorganic or organic barn exert on warm-blooded animals a protective action on the stomach and liver, and in addition they bring about an increase in the secretion of the pancreas and liver. In addition, they cause an inhibition of the formation of glucose from lactate and pyruvate in the liver. They are suitable for the treatment and prophylaxis of diseases which are due to disorders of the stomach or intestine or to reduced performances by the pancras, bile and/or liver. Processes for the production of the compounds and corresponding pharamaceutical products are given.
Patent AU-704606-B2 (AU)
Title: Human restrictin and nucleic acid sequences
Inventor: REID ROBERT ALAN
IPC: C12N15/09
Filed: 1996-03-14
Granted: 1999-04-29
Abstract: Human restrictin proteins and nucleic acid sequences encoding them are provided. Antibodies which recognize human restrictin in human brain are disclosed. In the human brain, restrictin occurs as two major polypeptides of 180 and 160 kD located in fiber tracts. These polypeptides are similar to those seen in rat brain. Surprisingly, restrictin has also been found in the peripheral nerves of rats and humans. The antibodies also detect a 170 kD polypeptide in MATRIGEL, an extracellular matrix product of rat EHS sarcoma cells widely used as a tissue culture substrate. Monoclonal antibodies to human restrictin and assays using the human restrictin protein, antibodies and DNA sequences are also provided.
Patent AU-663841-B2 (AU)
Title: Network control system
Inventor: WOEST KAREN L
IPC: H04L29/08
Filed: 1994-01-31
Granted: 1995-10-19
Abstract: A network control system for use in a communication network controls the receipt and transmission of messages between at least a pair of nodes of the network. Messages conveyed within the network include short messages having a length less than a predetermined number of bytes and long messages having a length greater than the predetermined number of bytes. The network control system is located at least at one of the nodes and includes a connectionless network control portion for controlling the transmission and receipt of the short messages and a connection-oriented network control portion coupled to the connectionless network control portion for establishing a connection with the other node for controlling the transmission and receipt of the long messages between the pair of nodes. The connectionless portion of the system includes a transport stage which provides end-to-end reliability within the system, a network stage for establishing routing of the messages, and a data link stage for providing point-to-point reliability and other control functions such as message flow control, node resynchronization, and node suspension. The connection-oriented portion of the system includes a session stage for handling the communication of long messages greater then the predetermined number of bytes in length.
Patent AU-708327-B2 (AU)
Title: A pluripotent vaccine against enveloped viruses
Inventor: MORTON DONALD L
IPC: A61K38/00
Filed: 1996-04-24
Granted: 1999-08-05
Abstract: The present invention is directed to compositions and methods for the induction of immune responses in mammals against enveloped animal viruses. More particularly, the invention provides vaccine compositions containing multiple MHC allotypes. By generating an immune response against these MHC molecules, virus or virus-infected cells expressing foreign MHC molecules can be attacked prior to infection of cells in the immunized host. In some embodiments, the vaccine compositions contain viral antigens and adjuvants as well. The vaccine compositions may comprise intact cells, cell-derived membrane preparations or recombinantly or chemically produced MHC molecules or fragments thereof.
Patent AU-736308-B2 (AU)
Title: Antitussive drugs delivered by ion exchange resins
Inventor: WEN BETTY P
IPC: A61K47/48
Filed: 1997-11-19
Granted: 2001-07-26
Abstract: The present invention relates generally to a mixture of coated and non-coated sulfonic acid cation exchange resins (Amberlite IR69) cross-linked with about 8% divinyl benzene onto which dextromethorphan has been loaded. About 30% of the drug/resin complexes are coated with a mixture of ethyl cellulose or ethyl cellulose latexes with plasticizers and water dispersible polymers such as SURELEASE. The coating level is about 50% w/w drug. Coated and uncoated drug/resin complexes are loaded with drug to about 45% by weight drug/resin complex. The ratio of coated and uncoated drug/resin complexes is about 55/45. The particle sizes of the coated and uncoated drug/resin complexes is about 20 to about 300 and about 20 to about 250 microns, respectively.
Patent AU-620716-B2 (AU)
Title: Photoimageable compositions
Inventor: FLYNN KATHY M
IPC: G03F7/027
Filed: 1990-05-25
Granted: 1992-02-20
Abstract: A photoimageable composition for forming a solder mask has a photopolymerizable acrylate chemical system which renders exposed portions insolvable to alkaline aqueous developers and an epoxy chemical system which hardens the composition after exposure and development. The acrylate chemical system comprises acrylate monomers, epoxy-acrylate oligomers and a photoinitiator. The epoxy chemical system comprises an epoxy resin and a curative therefore. The composition further comprises a cross-linking agent which is reactive with hydroxyl groups of the acrylate and epoxy chemical systems.
Patent AU-627586-B2 (AU)
Title: Orthopedic casting materials having superior lamination characteristics and methods for preparing same
Inventor: SCHOLZ MATTHEW THOMAS
IPC: A61F13/00
Filed: 1990-06-12
Granted: 1992-08-27
Abstract: The present invention relates to novel orthopedic casting materials having superior layer to layer lamination, and methods for preparing the same. The orthopedic casting materials comprise a resin-coated scrim having a plurality of projections along at least one surface thereof. Preferably, each projection comprises a bundle of at least about 8 filaments, and the scrim has from about 75 to about 1500 projections per gram of scrim. The projections serve to mechanically interact with adjacent layers of the material, thereby significantly enhancing the lamination properties of the resultant material and resisting delamination once the material has cured.
Patent AU-532903-B2 (AU)
Title: Producing record discs
Inventor: HOLMES JOHN R
IPC: B29C61/00
Filed: 1980-04-11
Granted: 1983-10-20
Abstract: An injection moulding apparatus for use in producing centrally-apertured video disc records (10). The apparatus includes first and second mould halves (11, 17) reciprocally movable with respect to each other between a closed position, wherein the two mould halves are in proximity to each other and molten plastic material is injected into a planar, annular cavity defined therebetween to form the record disc, and an open position, wherein the two mould halves are spaced apart from each other and the moulded record disc can be removed. The moulding apparatus further includes first and second annular rings (41, 43) carried by the respective first and second mould halves and defining the outer perimeter of the cavity. The first mould half includes two plates (13, 15) reciprocally vable with respect to each other, with a plurality of compression springs in the form of polyurethane blocks (105) interposed between the two plates, to bias the two annular rings into compressive engagement with each other when a central aperture is being punched in the moulded record disc.
Patent AU-646409-B2 (AU)
Title: Oil treatment method
Inventor: NOONAN WILLIAM R
IPC: A62D101/20
Filed: 1990-09-26
Granted: 1994-02-24
Abstract: What is disclosed is a method of encapsulating hydrocarbon systems with the combination of an emulsifier solution and a reactive silicate solution. The method comprises the addition of an emulsifier solution to a hydrocarbon, for example, crude oil, then adding the reactive silicate solution to the emulsifier solution and hydrocarbon mix. Upon adding the reactive silicate solution the mix changes to a thick gel consisting of agglomerates of microspheres having typical diameters of 2 to 4 micrometres and less. The agglomerates are only loosely bound and the microspheres are easily dispersable into individual entities. Upon drying the wet gel yields a free-flowing powder. The encapsulation does not chemically alter or degrade the oil in any way.
Patent AU-746984-B2 (AU)
Title: Stent for vessels
Inventor: IGAKI KEIJI
IPC: A61F2/90
Filed: 1998-03-31
Granted: 2002-05-09
Abstract: A stent for a vessel inserted in use into the vessel of a living body including a tubular member constituting a passageway from one end to its opposite end. The tubular member includes a main mid portion and low tenacity portions formed integrally with both ends of the main mid portion. The low tenacity portions are lower in tenacity than the main mid portion. These low tenacity portions are formed so as to have the Young's modulus approximate to that of the vessel of the living body in which is inserted the stent, so that, when the stent is inserted into the vessel, it is possible to prevent stress concentrated portions from being produced in the vessel. <IMAGE>
Patent AU-670376-B2 (AU)
Title: Parallel I/O network file server architecture
Inventor: ROW EDWARD JOHN
IPC: G06F15/16
Filed: 1994-06-23
Granted: 1996-07-11
Abstract: A file server architecture is disclosed, comprising as separate processors, a network controller unit (110), a file controller unit (112) and a storage processor unit (114). These units incorporate their own processors, and operate in parallel with a local Unix host processor (118). All networks are connected to the network controller unit (110), which performs all protocol processing up through the NFS layer. The virtual file system is implemented in the file controller unit (112) and the storage processor (114) provides high speed multiplexed access to an array of mass storage devices. The file controller unit (112) controls file information caching through its own local cache buffer, and controls disk data caching through a large system memory which is accessible on a bus by any of the processors. <IMAGE>
Patent AU-671746-B2 (AU)
Title: Low product alarm for solid products
Inventor: THOMAS JOHN E
IPC: G01J1/02
Filed: 1994-03-31
Granted: 1996-09-05
Abstract: A low product level detector is disclosed which utilizes a sensor comprised of an infrared emitter and receiver to project a beam of light across a cavity/enclosure which contains a solid product. When the product reaches a level at which more solid product should be added, an alarm indicia means is triggered. The alarm indicia means is comprised of an audible horn and a visually perceptible light. The low product alarm is utilized in a dispenser for dispensing a wash chemical solution which has been created by dissolving a solid wash chemical in a diluent. By maintaining a predetermined amount of solid wash chemical in the dispenser, the wash chemical solution maintains a more constant concentration.
Patent AU-774900-B2 (AU)
Title: Water ride attraction and nozzle assembly therefor
Inventor: LOCHTEFELD THOMAS J
IPC: A63G31/00
Filed: 2000-08-02
Granted: 2004-07-15
Abstract: A mobile and compact simulated-wave water ride attraction is provided having one or more sluice slide-over covers for ensuring the safety of riders in the absence of an extended transition surface or using a shortened transition surface. Advantageously, the ride attraction comprises a plurality of transportable modules and other associated components that can be shipped between sites using trucks, trains or other transportation means. The slide-over sluice cover advantageously enables riders to safely slide over the sluice gate and/or injection nozzle without risk of injury or interference with ride operation. The sluice cover comprises a contoured flexible pad which covers and extends over the top surface of the sluice gate. A flexible tongue is provided which is urged downward squeezing against the flow and sealing the nozzle area off from possible injurious contact from a rider. The shape of the tongue also provides a short transition surface over the top of which a rider can slide without injury. A padded fixed decking is provided and in conjunction with the sluice cover it allows the rider to perform a variety of new and exciting skimming/surfing tricks and maneuvers.
Patent AU-546010-B2 (AU)
Title: Method of oral contraception
Inventor: JAGER EVERT DE
IPC: A61K31/565
Filed: 1981-03-10
Granted: 1985-08-08
Abstract: The invention relates to a multiphase combination-type sequential preparation for oral contraception consisting of 20-22 tablets each containing a gestagen and an oestrogen wherein a first phase consists of 5-8 tablets, each of which contains a low dose of gestagen and a relatively high dose of oestrogen, a second phase of 5-8 tablets each having a gestagen dose which is greater than that during the first phase and an oestrogen dose which is smaller than that in the first phase, and a third phase of 5-11 tablets each of which has a gestagen dose equal to or greater than that during the second phase and an oestrogen dose equal to or less than that in the second phase, and to a method of oral contraception using said preparation.
Patent AU-599955-B2 (AU)
Title: Restrictor valve
Inventor: MCENEARNEY PAUL
IPC: F16K47/16
Filed: 1987-02-10
Granted: 1990-08-02
Abstract: PCT No. PCT/AU87/00035 Sec. 371 Date Dec. 7, 1987 Sec. 102(e) Date Dec. 7, 1987 PCT Filed Feb. 10, 1987 PCT Pub. No. WO87/04766 PCT Pub. Date Aug. 13, 1987.A restrictor is mounted within a passage of a control valve. The restrictor includes an annular disc having openings for the passage of fluid therethrough. The restrictor also includes a conical element coaxial with the annular disc. The restrictor limits the maximum discharge rate of fluid through the passage of the control valve.
Patent AU-699009-B2 (AU)
Title: Golf club strike indicator
Inventor: HOPE NORMAN BRADBURN
IPC: A63B69/36
Filed: 1994-06-10
Granted: 1998-11-19
Abstract: PCT No. PCT/CA94/00315 Sec. 371 Date Dec. 11, 1995 Sec. 102(e) Date Dec. 11, 1995 PCT Filed Jun. 10, 1994 PCT Pub. No. WO94/28982 PCT Pub. Date Dec. 22, 1994A self-adhesive indicator which adheres to a golf club face to provide an indication of the point of impact of the golf ball on the club face is provided. It consists of a sandwich of various layers-a layer of pressure-sensitive adhesive on the bottom, followed by a layer of energy-absorbing elastomeric material on which is provided a film of a thermochromic material such as a temperature sensitive liquid crystal, followed by a top layer of clear high impact plastic.
Patent AU-635997-B2 (AU)
Title: Oral immunoglobulin collection for immunoassay
IPC: A61B10/00
Filed: 1991-01-25
Granted: 1993-04-08
Abstract: The present invention is concerned with collecting immunoglobulins from the oral cavity for immunological testing. A rinse and an absorbent pad are used to collect a specimen having a high concentration of immunoglobulins. The specimen can be subjected to a basic immunological testing technique which can be used as a tool for screening a patient for diseases. A test kit is also provided for.
Patent AU-599636-B2 (AU)
Title: Transglutaminase inhibitors
Inventor: CASTELHANO ARLINDO L
IPC: C07C261/04
Filed: 1987-03-13
Granted: 1990-07-26
Abstract: The present invention is directed to certain 3, 5 substituted, 4, 5-dihydroisoxazoles, and methods for their use. These compounds are transglutaminase inhibitors, and are particularly effective in the inhibition of epidermal transglutaminase and the treatment of acne.
Patent AU-644133-B2 (AU)
Title: Low molecular weight copolymer amides
Inventor: LENCES CHARLES FRANCIS
IPC: C08G81/02
Filed: 1990-12-12
Granted: 1993-12-02
Abstract: A low molecular weight copolymer reaction product of a copolymer acid of an  alpha -olefin and an unsaturated carboxylic acid, preferably an  alpha , beta -ethylenically unsaturated carboxylic acid, and at least one amino acid compound. The present invention includes a method of preparing the copolymer reaction product. The reaction product has excellent compatibility with other polymers, particularly polyamides. The copolymer reaction product is useful in a method to flush water from pigments.
Patent AU-731553-B2 (AU)
Title: Neutrokine alpha
Inventor: YU GUO-LIANG
IPC: C12N1/21
Filed: 1996-10-25
Granted: 2001-04-05
Abstract: The present invention relates to a novel Neutrokine alpha protein which is a member of the TNF protein family. In particular, isolated nucleic acid molecules are provided encoding the human Neutrokine alpha protein including soluble forms of the extracellular domain. Neutrokine alpha polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of Neutrokine alpha activity. Also provided are diagnostic methods for detecting immune system-related disorders and therapeutic methods for treating immune system-related disorders.